豬血清市場規模、佔有率和成長分析：按產品類型、加工方法、應用、等級、最終用戶和地區分類－2026-2033年產業預測

2024 年全球豬血清市場價值為 9.874 億美元，預計到 2025 年將成長至 10.5849 億美元，到 2033 年將成長至 18.4607 億美元，在預測期（2026-2033 年）內複合年成長率為 7.2%。

全球豬血清市場因其生物活性和高蛋白含量而對多種應用至關重要，尤其是在細胞培養、疫苗生產和診斷檢測領域，這使其與哺乳動物細胞株具有高度親和性。該市場正經歷顯著成長，主要得益於生物技術的進步以及研發和藥物開發中對動物源性血清日益成長的依賴。個人化醫療也在推動需求成長，因為穩定的血清品質對於高通量細胞篩檢至關重要。製造商，尤其是在新興經濟體，正在應用純化​​技術以滿足嚴格的GMP標準，從而增強供應鏈韌性並降低成本。此外，人工智慧驅動的分析正在將銷售數據轉化為洞察，進一步提高需求預測的準確性，提升生產效率，並協助企業回應生命科學研究的動態需求。

全球豬血清市場成長要素

全球豬血清市場成長的主要驅動力是研究人員和製藥公司對豬血清日益成長的依賴。這是因為豬血清富含蛋白質，且適用於多種細胞株對於有效的治療試驗至關重要。隨著生物製藥和基因療法需求的持續成長，對穩定、高品質血清的需求也隨之增加。這促使生產商提高產能並改善純化技術。此外，對實驗可重複性和符合監管標準的重視也推動了市場成長，進而促使企業加強對全球採購、品質保證以及整個供應鏈穩健性的投入。

全球豬血清市場限制因素

全球豬血清市場面臨許多限制因素，主要源自於監管動物性生物材料的機構所實施的嚴格法規。這些法規要求對來源、加工和可追溯性進行詳盡的記錄，這無疑會使營運變得複雜。此外，出於對通用傳播和倫理問題的擔憂，生產者必須採取全面的檢測和檢驗措施，這進一步增加了營運的複雜性。遵守合規要求可能會導致產品核准延遲和成本增加，可能阻礙一些研究機構使用感染疾病血清。因此，這種監管環境構成了准入壁壘，阻礙了新供應商快速建立可靠的分銷網路，並抑制了市場成長。

全球豬血清市場趨勢

全球豬血清市場正經歷著向創新蛋白替代品的顯著轉變，製造商正不斷探索重組蛋白和植物來源替代品。這項轉變的主要驅動力是消費者對符合倫理標準的生物製品的需求日益成長，以及對動物性材料日益成長的擔憂。為了應對這些挑戰，各公司正與專注於生長因子的生技公司合作，開發出符合甚至超越現有性能標準的無血清培養基。隨著研究機構在細胞培養和疫苗研發中擴大採用這些替代品，預計市場將實現多元化，在降低對動物性原料依賴的同時，增強供應鏈韌性，並改善市場認知。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球豬血清市場規模：依產品類型分類

• 胎豬血清
• 新生仔豬血清
• 成年豬血清
• 其他

全球豬血清市場規模：依加工方法分類

• 標準血清
• 熱去活化血清
• 過濾血清
• 透析血清
• 其他

全球豬血清市場規模：依應用領域分類

• 細胞培養
• 疫苗生產
• 診斷試劑
• 出於研究目的
• 其他

全球豬血清市場規模：依等級分類

• 研究級
• GMP級
• 其他

全球豬血清市場規模：依最終用戶分類

• 生技公司
• 製藥公司
• 學術研究機構
• 診斷檢查室
• 其他

全球豬血清市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Cytiva
• Biowest SAS
• PAN-Biotech GmbH
• Atlas Biologicals, Inc.
• Bovogen Biologicals Pty Ltd.
• Bio-Techne Corporation
• Capricorn Scientific GmbH
• HiMedia Laboratories Pvt. Ltd.
• Serana Europe GmbH
• Moregate Biotech
• Biological Industries Israel Beit Haemek Ltd.
• TCS Biosciences Ltd.
• GeminiBio Products LLC
• ZenBio, Inc.
• R&D Systems, Inc.
• WISENT Inc.
• Lifeline Cell Technology
• ScienCell Research Laboratories, Inc.

結論與建議

Global Porcine Serum Market size was valued at USD 987.4 Million in 2024 and is poised to grow from USD 1058.49 Million in 2025 to USD 1846.07 Million by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The global porcine serum market is vital for various applications, notably in cell culture, vaccine production, and diagnostic assays, owing to its biologically active nature and high protein content that aligns well with mammalian cell lines. The market has seen significant expansion, largely driven by advancements in biotechnology and an increasing reliance on animal-derived serums for research and pharmaceutical development. Personalization in medicine is also fueling demand, as high-throughput cell-based screening necessitates consistent serum quality. Manufacturers are embracing purification technologies to meet stringent GMP standards, particularly in emerging economies, which strengthens supply-chain resilience and reduces costs. AI-driven analytics are further enhancing demand forecasting by transforming sales data into insights that improve production efficiency and align with the dynamic needs of life-science research.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Porcine Serum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Porcine Serum Market Segments Analysis

Global porcine serum market is segmented by product type, processing type, application, grade, end user and region. Based on product type, the market is segmented into Fetal Porcine Serum, Newborn Porcine Serum, Adult Porcine Serum and Others. Based on processing type, the market is segmented into Standard Serum, Heat-Inactivated Serum, Filtered Serum, Dialyzed Serum and Others. Based on application, the market is segmented into Cell Culture, Vaccine Production, Diagnostic Reagents, Research Applications and Others. Based on grade, the market is segmented into Research Grade, GMP Grade and Others. Based on end user, the market is segmented into Biotechnology Companies, Pharmaceutical Companies, Academic & Research Institutes, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Porcine Serum Market

The Global Porcine Serum market is significantly driven by the increasing reliance of researchers and pharmaceutical companies on porcine serum, thanks to its rich protein content and versatility across various cell lines, which are crucial for effective therapeutic testing. As the demand for biologics and gene therapies continues to grow, the necessity for consistent, high-quality serum becomes even more pronounced. This stimulates manufacturers to enhance production capacities and refine purification techniques. Additionally, the focus on experimental reproducibility and adherence to regulatory standards contributes to market growth, leading to heightened investments in sourcing, quality assurance, and the overall robustness of supply chains on a global scale.

Restraints in the Global Porcine Serum Market

The Global Porcine Serum market faces significant constraints due to stringent regulations imposed by authorities overseeing animal-derived biological materials. These regulations necessitate thorough documentation related to sourcing, processing, and traceability, which can complicate operations. Additionally, concerns about zoonotic disease transmission and ethical issues prompt manufacturers to adopt comprehensive testing and validation measures, further increasing operational complexities. The demands of compliance can lead to delays in product approvals and raise costs, which may deter some research laboratories from utilizing porcine serum. Consequently, this regulatory landscape creates barriers to entry and restricts the rapid establishment of dependable distribution networks for new suppliers, hindering market growth.

Market Trends of the Global Porcine Serum Market

The Global Porcine Serum market is witnessing a significant trend towards innovative protein substitutes as manufacturers increasingly explore recombinant and plant-based alternatives. This shift is primarily fueled by rising consumer demand for ethically sourced bioproducts and growing concerns regarding animal-derived materials. To address these challenges, companies are forming partnerships with biotechnology firms that specialize in growth factors, leading to the development of serum-free media that can meet or surpass existing performance benchmarks. As laboratories increasingly adopt these alternatives for cell culture and vaccine development, the market is positioned to diversify, reducing dependence on animal sourcing while enhancing supply chain resilience and positive market perceptions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Porcine Serum Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Fetal Porcine Serum
• Newborn Porcine Serum
• Adult Porcine Serum
• Others

Global Porcine Serum Market Size by Processing Type & CAGR (2026-2033)

• Market Overview
• Standard Serum
• Heat-Inactivated Serum
• Filtered Serum
• Dialyzed Serum
• Others

Global Porcine Serum Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cell Culture
• Vaccine Production
• Diagnostic Reagents
• Research Applications
• Others

Global Porcine Serum Market Size by Grade & CAGR (2026-2033)

• Market Overview
• Research Grade
• GMP Grade
• Others

Global Porcine Serum Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biotechnology Companies
• Pharmaceutical Companies
• Academic & Research Institutes
• Diagnostic Laboratories
• Others

Global Porcine Serum Market Size & CAGR (2026-2033)

• North America (Product Type, Processing Type, Application, Grade, End User)
  • US
  • Canada
• Europe (Product Type, Processing Type, Application, Grade, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Processing Type, Application, Grade, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Processing Type, Application, Grade, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Processing Type, Application, Grade, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biowest SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAN-Biotech GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atlas Biologicals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bovogen Biologicals Pty Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capricorn Scientific GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiMedia Laboratories Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serana Europe GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moregate Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological Industries Israel Beit Haemek Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TCS Biosciences Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeminiBio Products LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZenBio, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R&D Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WISENT Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifeline Cell Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations